The statement critiques the FDA's role in prioritizing large pharmaceutical companies over innovation, in the context of a promising new cancer treatment. It suggests a need for policy change to better support innovative therapies.
- The statement aims to highlight a perceived issue in the healthcare system, potentially advocating for change to benefit public health, aligning with the principle of doing no harm. [+1]Principle 1:I will strive to do no harm with my words and actions.
- By promoting innovation in cancer treatment, the statement encourages empathy and compassion for patients needing advanced therapies. [+1]Principle 3:I will use my words and actions to promote understanding, empathy, and compassion.
- The statement uses its platform to advocate for systemic change, aiming to improve societal health outcomes. [+1]Principle 6:I will use my influence for the betterment of society.